Rare diseases
Investigational molecules
Locations
Back to Czechia1 217 clinical trials in Prague, Czechia across 18 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study of felzartamab compared to placebo in adults with IgA nephropathy
CzechiaStudy of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo
CzechiaStudy of GHZ339 for treatment of moderate to severe atopic dermatitis
CzechiaStudy of Mezagitamab in Adults with Primary IgA Nephropathy (Berger's Disease) to Reduce Protein in Urine
CzechiaStudy of human normal immunoglobulin and teclistamab for infection prevention in adults with multiple myeloma receiving B-cell maturation antigen therapy
CzechiaStudy of Plozasiran to prevent acute pancreatitis in adults with severe hypertriglyceridemia
CzechiaStudy of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia
CzechiaStudy of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis
CzechiaStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
CzechiaStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
CzechiaStudy of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration
CzechiaStudy of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on TTR amyloidosis and heart disease treatments, alongside studies investigating hypertriglyceridemia management with novel therapeutics.
Multiple trials evaluating new therapeutic approaches for heart failure prevention and treatment.
Comprehensive studies in prostate cancer and multiple myeloma, with particular focus on metastatic conditions and novel treatment combinations.
Advanced trials comparing innovative therapies against standard treatments in various cancer types.
Extensive vaccine development programs including meningococcal and chickenpox vaccines, alongside studies in immune system disorders.
Focus on immunogenicity and safety in various age groups from infants to adults.
Research into chronic rhinosinusitis and COPD, along with studies on inflammatory bowel conditions.
Evaluating new therapeutic approaches for chronic respiratory and inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
